These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 1693101
1. The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies. Sohen S, Rothstein DM, Tallman T, Gaudette D, Schlossman SF, Morimoto C. Cell Immunol; 1990 Jun; 128(1):314-28. PubMed ID: 1693101 [Abstract] [Full Text] [Related]
2. Increased frequencies of the CD29 and CD57 markers and decreased frequency of CD45RA within CD4+ and CD8+ subsets after allogeneic bone marrow transplantation in man. Møller J, Dickmeiss E, Ryder LP, Jacobsen N, Svejgaard A. Scand J Immunol; 1991 May; 33(5):499-504. PubMed ID: 1709516 [Abstract] [Full Text] [Related]
3. Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes. Richards SJ, Jones RA, Roberts BE, Patel D, Scott CS. Clin Exp Immunol; 1990 Jul; 81(1):149-55. PubMed ID: 1974177 [Abstract] [Full Text] [Related]
6. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II. Lal RB, Rudolph DL, Schmid DS, Lairmore MD. Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929 [Abstract] [Full Text] [Related]
7. Equivalent helper functions of human "naive" and "memory" CD4+ T cells for the generation of alloreactive cytotoxic T lymphocytes. Yamashita N, Bullington R, Clement LT. J Clin Immunol; 1990 Sep; 10(5):237-46. PubMed ID: 1979982 [Abstract] [Full Text] [Related]
8. Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells. Kalish RS, Morimoto C, Schlossman SF. Cell Immunol; 1988 Feb; 111(2):379-89. PubMed ID: 2962747 [Abstract] [Full Text] [Related]
9. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation. Rudd CE, Anderson P, Morimoto C, Streuli M, Schlossman SF. Immunol Rev; 1989 Oct; 111():225-66. PubMed ID: 2534114 [Abstract] [Full Text] [Related]
10. Aberrant distribution of CD4 and CD8 lymphocyte subsets in recent-onset IDDM patients. Effect of cyclosporin. Chatenoud L, Volpini W, Timsit J, Boitard C, Bach JF. Diabetes; 1993 Jun; 42(6):869-75. PubMed ID: 7684344 [Abstract] [Full Text] [Related]
14. CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes. Matsuyama T, Yamada A, Rothstein DM, Anderson KC, Schlossman SF, Morimoto C. Cell Immunol; 1991 Oct 15; 137(2):406-19. PubMed ID: 1716520 [Abstract] [Full Text] [Related]
15. Immobilized anti-CD3-induced T cell growth: comparison of the frequency of responding cells within various T cell subsets. Geppert TD, Lipsky PE. Cell Immunol; 1991 Mar 15; 133(1):206-18. PubMed ID: 1703926 [Abstract] [Full Text] [Related]
16. The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation. Akbar AN, Amlot PL, Timms A, Lombardi G, Lechler R, Janossy G. Clin Exp Immunol; 1990 Aug 15; 81(2):225-31. PubMed ID: 1974831 [Abstract] [Full Text] [Related]
18. CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A. Rothstein DM, Sohen S, Daley JF, Schlossman SF, Morimoto C. Cell Immunol; 1990 Sep 15; 129(2):449-67. PubMed ID: 1696528 [Abstract] [Full Text] [Related]
20. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. Benito JM, Zabay JM, Gil J, Bermejo M, Escudero A, Sánchez E, Fernández-Cruz E. J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb 01; 14(2):128-35. PubMed ID: 9052721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]